Abstract
Despite clinical advances, ischemic heart disease continues to be a major cause of morbidity and mortality worldwide. Prolonged cardiac ischemia and loss of cardiomyocytes frequently result in progressive pathological remodeling of the myocardium. If the heart is unable to adapt, patients may succumb to terminal heart failure. Cardiac tissue regeneration combining biodegradable biomaterials and stem cells has emerged as a new approach to restore heart function. Biomaterials, including injectable hydrogels and spongy scaffolds, can facilitate stem cell engraftment and survival and prevent adverse ventricular remodeling. Promising early results with injectable, biodegradable hydrogels for cardiac repair have provided new opportunities for designing innovative therapies to treat injured hearts.
Hydrogels can be made from natural or synthetic polymers and have a water content, flexibility, and other physiochemical characteristics similar to those of living tissue, which makes them excellent candidates for tissue repair. In addition, hydrogels can be used as a vehicle to deliver cytokines or cells to the heart and can be employed to encapsulate biological macromolecules or cells and release them into the surrounding tissues during degradation. Hydrogels undergo physicochemical modifications in response to changes in temperature or pH, depending upon their polymer composition, converting from a liquid to a gel. The gel form retains cytokine molecules, allows their prolonged, controlled release, and preserves their bioactivity for extended periods. Polyethylene glycol is a water-soluble, biocompatible polymer that has negligible immunogenicity and can produce efficient conjugation of hydrogels to growth factors. In this chapter, we provide insight into the composition, polymerization, and use of a temperature-sensitive, biodegradable, aliphatic polyester hydrogel that transforms to a gel at physiological temperatures and is a potential candidate for cardiac tissue regeneration.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leor J, Tuvia S, Guetta V et al (2009) Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J Am Coll Cardiol 54:1014–1023
Ifkovits JL, Tous E, Minakawa M et al (2010) Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A 107:11507–11512
Wu J, Zeng F, Huang XP et al (2011) Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials 32:579–586
Singelyn JM, Sundaramurthy P, Johnson TD et al (2012) Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol 59:751–763. doi:10.1016/j.jacc.2011.10.888
Sabbah HN, Wang M, Gupta RC et al (2013) Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. J Am Coll Cardiol Heart Failure 1:252–258. doi:10.1016/j.jchf.2013.02.006
Balsam LB, Wagers AJ, Christensen JL et al (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668–673
Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705
Tomita S, Li RK, Weisel RD et al (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247–II256
Assmus B, Honold J, Schachinger V et al (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222–1232
Schachinger V, Erbs S, Elsasser A et al (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210–1221
Christman KL, Lee RJ (2006) Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48:907–913
Kang K, Sun L, Xiao Y et al (2012) Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration. J Am Coll Cardiol 60:2237–2249. doi:10.1016/j.jacc.2012.08.985
Ueno T, Pickett LC, de la Fuente SG, Lawson DC, Pappas TN (2004) Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg 8:109–112
Zhao ZQ, Puskas JD, Xu D et al (2010) Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. J Am Coll Cardiol 55:1250–1261
Christman KL, Vardanian AJ, Fang Q et al (2004) Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44:654–660
Peppas NA, Keys KB, Torres-Lugo M, Lowman AM (1999) Poly(ethylene glycol)-containing hydrogels in drug delivery. J Control Release 62:81–87
Yonet-Tanyeri N, Rich MH, Lee M et al (2013) The spatiotemporal control of erosion and molecular release from micropatterned poly(ethylene glycol)-based hydrogel. Biomaterials 34:8416–8423
Torres DS, Freyman TM, Yannas IV, Spector M (2000) Tendon cell contraction of collagen-GAG matrices in vitro: effect of cross-linking. Biomaterials 21:1607–1619
Brannon-Peppas L (1990) Preparation and characterization of crosslinked hydrophilic networks. In: Brannon-Peppas L, Harland RS (eds) Absorbent polymer technology. Elsevier, Amsterdam, pp 45–66
Miyagi Y, Zeng F, Huang XP et al (2010) Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. Biomaterials 31:7684–7694
Salimath AS, Phelps EA, Boopathy AV et al (2012) Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One 7:e50980. doi:10.1371/journal.pone.0050980
Hassan W, Dong Y, Wang W (2013) Encapsulation and 3D culture of human adipose-derived stem cells in an in-situ crosslinked hybrid hydrogel composed of PEG-based hyperbranched copolymer and hyaluronic acid. Stem Cell Res Ther 4:32
Dhingra S, Li P, Huang XP et al (2013) Preserving PGE2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores post-infarction ventricular function. Circulation 128:S1–S10
Acknowledgement
Dr. Ren-Ke Li holds a Canada Research Chair in Cardiac Regeneration.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Dhingra, S., Weisel, R.D., Li, RK. (2014). Synthesis of Aliphatic Polyester Hydrogel for Cardiac Tissue Engineering. In: Radisic, M., Black III, L. (eds) Cardiac Tissue Engineering. Methods in Molecular Biology, vol 1181. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1047-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1047-2_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1046-5
Online ISBN: 978-1-4939-1047-2
eBook Packages: Springer Protocols